Web Content Management
PRODUCTS
-
With 360water Plus, unlock unlimited access to online education.
-
In today’s complex clinical research landscape, sponsors and CROs face numerous challenges that can impact study timelines, costs, and data quality. The iMednet platform offers innovative solutions to address these critical issues.
-
Navigating your biopharma lifecycle
Meet IDBS Polar, the world’s first BioPharma Lifecycle Management (BPLM) platform, eliminating repetitive manual tasks, allowing you to efficiently execute your processes while curating the data you need to accelerate time to market by tackling the biggest challenges in process design, optimization, scale-up and technology transfer.
-
Compliance solutions for product development agility and audit readiness.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
WHITE PAPERS AND CASE STUDIES
-
Leeton Shire Improves Efficiency And Service Levels With An Affordable, Intuitive Digital Solution
Although Leeton Shire already had some digital technologies in place, such as SCADA, GIS and AMI, they lacked hydraulic modeling capabilities and expertise — which is why they turned to Qatium’s open and secure water management platform.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
Trial Rescue: Leadership Approach To Propel Clinical Development
Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
-
PlantPAx Distributed Control System Reduces Downtime For Mallinckrodt
Learn how the nation's leading supplier in prescription pain medication completely upgraded their control system, resulting in greater diagnostic/troubleshooting information and reducing downtime.
-
Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
-
Canadian Contractor Weathers Freezing Temperatures With Post-Coding
Discover why Uni-Jet's post-coding workflow relies on WinCan to overcome winter weather.
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
Streamlining Phase 1 Trials With The Mobile Vision Pod
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
-
eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality
Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
-
Revolutionizing The mmWave 5G Business Case
mmWave 5G is crucial for 5G's full potential. Innovative mmWave technology has made it commercially viable by offering high-performance, cost-effective solutions.
-
Optimal COA Measurement Strategy In Modern Oncology Trials: Insights
Explore the challenges and opportunities in implementing patient-reported outcome measures (PROMs) in oncology trials. This article discusses the recent FDA draft guidance, emphasizing how more targeted PROM strategies could lead to better medication labeling and patient care in cancer treatment.
NEWS
-
Public-Private Partnership Results In New Broccoli Hybrid, 'Northstar'9/25/2025
Broccoli is a staple vegetable in many U.S. households and is growing in popularity worldwide, but it’s picky – a temperate crop, it likes cooler nights and predictable weather, both harder to come by as the climate warms.
-
Philips And AWS Collaborate To Scale Digital Pathology In The Cloud, Enhancing Diagnostic Capabilities And Improving Productivity3/12/2024
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to address the growing need for secure, scalable digital pathology solutions in the cloud.
-
Solesis To Open First Manufacturing Site In Costa Rica Dedicated To Custom Polymer And Textile Healthcare Solutions2/2/2024
The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.
-
Kitcast Launches New Digital Signage Solution For Apple TV With Enhanced Features And Enterprise-Grade Functionality10/1/2024
Kitcast, a leader in digital signage software for Apple TV, is proud to announce the release of its new platform. It enables businesses of all sizes, educational institutions, and non-profit organizations to turn their digital displays into dynamic, engaging, and interactive communication tools.
-
Evotec SE Announces First Projects For LAB eN2 Drug Discovery Accelerator With Novo Nordisk12/11/2024
Evotec SE announced that its translational drug discovery accelerator with Novo Nordisk, LAB eN², which aims to nurture early research from academic institutions into novel therapeutics, has selected its first three projects to move forward in the program from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center.